Migraine Clinical Trials in Phoenix

Showing 1-20 of 94 trials

MMA Embolization for Refractory Chronic Migraine

NCT06735833

This is a prospective, multi-center, feasibility study to investigate safety and effectiveness of TRUFILL n-BCA liquid embolic system in bilateral middle meningeal artery (MMA) embolization for the treatment of refractory chronic migraine.

Migraine

Cerenovus, Part of DePuy Synthes Products, Inc.70 participantsStarted Apr 2025

Phoenix, Arizona, United States • Walnut Creek, California, United States • Hartford, Connecticut, United States +6 more locations

RECRUITINGPhase 3< 1 mile

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

NCT06641466

The purpose of this study is to evaluate the efficacy and safety of rimegepant when administered during the peri-menstrual period (PMP) for intermittent prevention of migraine in women who experience menstrual migraine attacks.

Menstrual Migraine

Pfizer723 participantsStarted Mar 2025

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +119 more locations

MMA Embolization for Refractory Chronic Migraine

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

Migraine Trials in Other Cities

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine

A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine

A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine

App-based Breathing Program for Migraine Relief

Light Exposure, Migraine Outcomes, and Sleep Quality

A Study of Remote Electrical Neuromodulation for Acute Procedural Pain

Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine

A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of Age

Initiating Early Control of Migraine Pain and Associated Symptoms

A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications

Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine

Safety and Efficacy Trial of MTX101 2mg for the Acute Treatment of Migraine in Adults

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks

Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

A Study to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents

Other Conditions in Phoenix